Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John T Leppert

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
European Urology|May 14, 2017
Applying Precision Oncology to Renal Cell Carcinoma: Emerging ChallengesJohn T Leppert
JAMA Network Open|March 22, 2021
Costs of Robotic-Assisted Radical Prostatectomy 1 Year After Surgery: Pay Now and Save Later?Bogdana Schmidt, John T Leppert
Urology Practice|May 5, 2023
Editorial CommentaryBogdana Schmidt, John T Leppert
JAMA Network Open|May 6, 2025
Overtreatment of Prostate Cancer in Men With Limited Life Expectancy-A Global Phenomenon?Timothy J Daskivich, John T Leppert
JAMA Network Open|January 26, 2021
In Search of Clinical Biomarkers of Response to Checkpoint Inhibitor Therapy in Renal Cell CarcinomaAlice C Fan, John T Leppert
Urology|May 28, 2014
Editorial commentPhilip V Barbosa, John T Leppert
JAMA Internal Medicine|May 5, 2025
Overtreatment in Prostate Cancer: An Overused Term-ReplyTimothy J Daskivich, John T Leppert
JAMA Network Open|August 15, 2019
Postmarketing Analysis of Sipuleucel-T-The Importance of Real-World DataAlice C Fan, John T Leppert
European Urology|July 19, 2018
Re: Brandon A. Mahal, David D. Yang, Natalie Q. Wang, et al. Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer. Eur Urol 2018;74:146-54John T Leppert, James D Brooks
The Journal of Urology|May 22, 2013
Turning on the lights: new technologies in optical diagnostics and therapeuticsJoseph C Liao, John T Leppert
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
European Urology|May 14, 2017
Applying Precision Oncology to Renal Cell Carcinoma: Emerging ChallengesJohn T Leppert
JAMA Network Open|March 22, 2021
Costs of Robotic-Assisted Radical Prostatectomy 1 Year After Surgery: Pay Now and Save Later?Bogdana Schmidt, John T Leppert
Urology Practice|May 5, 2023
Editorial CommentaryBogdana Schmidt, John T Leppert
JAMA Network Open|May 6, 2025
Overtreatment of Prostate Cancer in Men With Limited Life Expectancy-A Global Phenomenon?Timothy J Daskivich, John T Leppert
JAMA Network Open|January 26, 2021
In Search of Clinical Biomarkers of Response to Checkpoint Inhibitor Therapy in Renal Cell CarcinomaAlice C Fan, John T Leppert
Urology|May 28, 2014
Editorial commentPhilip V Barbosa, John T Leppert
JAMA Internal Medicine|May 5, 2025
Overtreatment in Prostate Cancer: An Overused Term-ReplyTimothy J Daskivich, John T Leppert
JAMA Network Open|August 15, 2019
Postmarketing Analysis of Sipuleucel-T-The Importance of Real-World DataAlice C Fan, John T Leppert
European Urology|July 19, 2018
Re: Brandon A. Mahal, David D. Yang, Natalie Q. Wang, et al. Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer. Eur Urol 2018;74:146-54John T Leppert, James D Brooks
The Journal of Urology|May 22, 2013
Turning on the lights: new technologies in optical diagnostics and therapeuticsJoseph C Liao, John T Leppert
Pageof 17